(Q34643123)

3 August 2017

title

A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity (English)

1 reference

3 August 2017

0 references

Clostridium difficile

0 references

1 reference

1 reference

Fred A Zar

1

1 reference

3 August 2017

Srinivasa R Bakkanagari

series ordinal

2

1 reference

3 August 2017

K M L S T Moorthi

series ordinal

3

1 reference

3 August 2017

Melinda B Davis

series ordinal

4

1 reference

3 August 2017

language of work or name

English

0 references

publication date

19 June 2007

1 reference

Clinical Infectious Diseases

3 August 2017

published in

1 reference

3 August 2017

volume

45

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

302-307

1 reference

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

3 August 2017

cites work

1 reference

Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis

21 January 2018

1 reference

Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea

21 January 2018

1 reference

Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada

21 January 2018

1 reference

Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada

21 January 2018

1 reference

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity

21 January 2018

1 reference

Severe Clostridium difficile colitis

21 January 2018

1 reference

Risk factors for early recurrent Clostridium difficile-associated diarrhea.

21 January 2018

1 reference

Factors associated with failure of metronidazole in Clostridium difficile-associated disease

21 January 2018

1 reference

Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial

21 January 2018

1 reference

Recommendations for preventing the spread of vancomycin resistance

21 January 2018

1 reference

Metronidazole for Clostridium difficile-associated disease: is it okay for Mom?

21 January 2018

1 reference

An epidemic, toxin gene-variant strain of Clostridium difficile

21 January 2018

1 reference

A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes

21 January 2018

1 reference

Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications

21 January 2018

1 reference

Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole

21 January 2018

1 reference

Diarrhea etiology in a Children's Hospital Emergency Department: a prospective cohort study.

21 January 2018

1 reference

Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin

21 January 2018

1 reference

Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile

21 January 2018

1 reference

A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit

21 January 2018

1 reference

Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus

21 January 2018

1 reference

Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients

21 January 2018

1 reference

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/519265

1 reference

3 August 2017

1 reference